Search Constraints
« Previous |
21 - 40 of 81
|
Next »
Search Results
Select an image to start the slideshow
Development of novel inhibitors of carbohydrate-processing targets involved in Mycobacterium tuberculosis cell wall biosynthesis
1 of 20
The development of small molecule inhibitors for fibrosis drug discovery
2 of 20
The synthesis & optimisation of irreversible ITK inhibitors as a potential new treatment for severe asthma
3 of 20
The design, synthesis and optimisation of epigenetic mechanism inhibitors
4 of 20
Automated, quantitative process analysis by NMR
5 of 20
New methods for the construction of selectively difluorinated carbocycles
6 of 20
Approaches to lead generation for idiopathic pulmonary fibrosis targets
7 of 20
Single electron transfer in organic synthesis targeted towards sustainable manufacture
8 of 20
The design, synthesis and optimisation of phosphoinositide-3-kinase (PI3K) inhibitors as potential anti-inflammatory agents
9 of 20
Sustainable cross-couplings for pharmaceutical scale-up using aryldiazonium salts
10 of 20
The synthesis and optimisation of toll-like receptor agonists as potential immunomodulatory agents
11 of 20
Structure-guided approaches to the design of novel autotaxin inhibitors
12 of 20
Investigating and exploiting best practices in hit identification and hit to lead chemistry
13 of 20
Pharmacological characterisation of the 5-HT receptors present on mouse and human hepatic stellate cells and their role in liver fibrosis
14 of 20
The design and synthesis of small molecule bromodomain inhibitors
15 of 20
The development of small molecules for treatment of idiopathic pulmonary fibrosis (IPF)
16 of 20
Understanding reaction mechanisms and structure/reactivity relationships in the electrophilic fluorination of enol esters
17 of 20
Increasing the saturation of BET inhibitors
18 of 20
Computational modelling of enzyme activity to speed up biocatalyst redesign
19 of 20
Iron-catalysed cross-couplings of secondary alkyl Grignard reagents
20 of 20